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Introduction 1
Bile duct disease accounts for approximately one third of adult and 70% of pediatric liver 2 transplants [1] , [2] . Several of these disorders are anatomically diffuse and affect the small 3 branches of the intrahepatic bile ducts that are not amenable to surgical replacement or 4 reconstruction. However, some of the most impactful cholangiopathies that require, or are a 5 consequence of, liver transplantation can be limited to the large ducts of the extrahepatic 6 biliary tree. These include biliary atresia, which constitutes the leading cause for pediatric liver 7 transplantation [1] , [3] and dominant ischemic strictures, which after rejection, represent one 8 of the most common causes of liver transplant failure [4] . Surgical replacement of the affected 9 bile ducts is a potentially effective treatment, but is currently hampered by the lack of suitable 10 healthy tissue. Portoenterostomy, which entails using a length of small intestine as a conduit 11
to enable bile flow from the liver to the gut, can be used as an alternative treatment. 12
Portoenterostomy, however, is associated with complications such as reflux cholangitis and 13 stricture formation [5] . Furthermore, it is not curative for the majority of the patients with biliary 14 atresia, who will proceed to need liver transplantation later in life [6] . 15
Tissue engineering could address the lack of primary tissue by combining cells, materials and 16 growth stimulating signals [7] to generate bioengineered bile ducts. Indeed, biliary tissue 17 generated in vitro could provide a viable alternative for the management of common bile duct 18 (CBD) disorders and potentially reduce the need for organ transplantation. However, despite 19 the significant progress in tissue engineering for many other organs over the last decade, the 20 generation of functional bile ducts in vitro has been hindered by a number of challenges. More 21 specifically, until recently there was a lack of robust culture systems for growing biliary 22 epithelial cells, which constitute the main functional cell population in the bile duct [8] , [9] . 23 Furthermore, the biliary system is very sensitive to ischemia necessitating the development of 24 fully vascularized constructs to ensure adequate supply of nutrients and oxygen [4] . Over the 25 last few years, there have been several breakthroughs in these fields leading to the first 26 studies of functional bioengineered bile duct transplantation. Here we provide a summary of 27 gallbladder [18] . The resulting organoids sustain the function and genetic profile of 1 extrahepatic cholangiocytes, survive in vivo, self-organize into tubular structures and can be 2 used to reconstruct the biliary epithelium following transplantation [18] . However, some 3 limitations still exist. In depth studies are required to elucidate the extent to which removing 4 these cells from their niche and propagating them in vitro impacts on their properties. 5
Furthermore, genetic modification of organoids is possible but remains more complicated 6 compared to cells grown in monolayers. Finally, access is more limited compared to hIPSCs 7 rendering the generation of autologous lines more difficult, although the use of gallbladder 8 tissue, accessed by surgical cholecystectomy, could resolve some of these issues. 9
Other cell types 10
The biliary epithelium is supported by a layer of connective tissue [19], containing fibroblasts 11 and elastic fibers ( Figure 1 ). The distal third of the CBD is also surrounded by a sheet of 12 smooth muscle [9] (Figure 1 ). Although these 'supportive' cell types do not demonstrate 13
properties specific to the biliary tree, they are important for the structural integrity and 14 nourishment of the bile duct and may contribute towards the mechanical properties for bio-15 engineered constructs. 16 17
Materials 18
The generation of bioengineered bile ducts requires incorporation of the cell types described 19 above into suitable materials that can be fabricated into a tubular structure. In tissue 20 engineering, a large variety of synthetic and biological materials can be used to produce 21 scaffolds that are capable of maintaining a population of cells in vitro or in vivo [20] . The choice 22 of appropriate material(s) for generating a suitable tubular matrix requires balancing a number 23 of parameters. For a given tube radius and wall thickness, the elastic and plastic properties of 24 the tube wall material are important for supporting the cells and maintaining an unobstructed 25 lumen for drainage of bile. The biocompatibility of the scaffold is not only essential for the 26 viability of the cells in the tube [21] , but also to prevent, or at least minimize, the inflammatory 27 response that is inherently associated with surgery and transplantation of tissues [22] . Control 28 6 of this inflammatory response is particularly critical for bile ducts, as it can otherwise lead to 1 fibro-inflammatory strictures and ultimately occlusion of the lumen [23], [24] . Finally, a material 2 which is bioresorbable is desirable since it permits eventual remodeling and replacement of 3 the scaffold with native cells and tissue [25] . 4
As expected, most materials fail to meet all the necessary requirements outlined above. such biological polymers include collagen [18] , collagen-agarose [32] , and collagen 18 membranes [33]. Hybrid scaffolds, such as tubes made from a polypropylene mesh and 19 collagen sponge have also been produced [34]. 20 21
Fabrication Techniques 22
There are a number of possible methods to fabricate the materials described earlier into 23 bioengineered patent tubular bile ducts. These include rolling of a polymeric sheet, molding, 24 3D printing techniques, electrospinning, freeze-drying, and cellular self-assembly approaches. 25
The simplest method for fabricating a uniaxial tube is to roll a polymeric sheet and suture along 26 its length. While making large-scale tubes is relatively simple using this approach, use of 27 suture material, even if absorbable, along the length of the native bile duct can lead to fibrosis 28 and strictures; portoenterostomy biliary reconstruction thus remains the current optimal 1 treatment for iatrogenic bile duct injury [35] [36]. 2
Polymers can be molded to form a variety of structures, including tubes [37] . This method has 3
the key advantage that, at least in the case of biological polymers, cells can be seeded into 4 the precursor polymer solution providing a method for incorporating cells inside a dense 5 scaffold [38], [39] . Alternatively, many polymers can be 3D printed, wherein a structure is 6 constructed layer-by-layer, via a number of different techniques [40]-[42]. This enables 7 complex architectures with very fine and reproducible features to be fabricated. However, we 8 note that 3D printing includes a wide range of different approaches and there are particular 9
challenges associated with each of these additive techniques [40], [41] . For example, 10 extrusion-based 3D printing struggles in producing overhanging features and small-diameter 11 tubes can collapse during fabrication [43] . Freeze-drying involves freezing and dehydrating a polymer solution to produce a macro-18 porous sponge architecture [46] [26] [33] . This allows seeded cells to penetrate deep inside the 19 scaffold and be maintained in a bioreactor, which is advantageous when forming structured 20 tissue. However, the high porosity of the scaffold makes them difficult to use as a conduit for 21 fluid such as bile. Indeed, in the context of biliary reconstruction, bile leakage through the wall 22 of porous scaffolds leads to biliary peritonitis [18] . Nevertheless, culturing the scaffolds in vitro 23
can allow cells to fill the pores within the matrix material to form a more robust and 24 impermeable tubular structure [47]. One notable method involves rolling a polyester felt sheet 25 into a tube between two concentric cylinders and filling the spacing with polyglycolic acid 26 (PGA) or polyL-lactic acid (PLLA) [47] . Using freeze-drying techniques, the solvent is then 27 removed and the scaffold seeded with cells, which can penetrate deep into the scaffold [47]. 28
Finally, it is possible to produce tubular structures with self-assembled cell sheets, bioprinting, 1 and other scaffold-free approaches in which cells are deposited directly to build a 3D structure 2
[48], [49] . However, these generally produce structures that are mechanically very weak and 3 require significant culture in vitro if to be used as a replacement conduit or vessel [26], [48] . 4
Importantly, for most materials and fabrication processes described, cells cannot be loaded 5
into the construct during the fabrication process since the processing environment is typically 6 too harsh and results in loss of cell viability (e.g. due to toxic chemicals, organic solvents, 7 acidity or high temperature). Cells are therefore usually loaded after processing of the scaffold 8 is complete via in vitro culturing techniques, such as with a bioreactor system, or by surgically 9
implanting the scaffold as an acellular construct and allowing for migration of native cells and 10 blood vessels. 11 12
Vascular supply 13
Bile ducts are very sensitive to ischemia [19], [50]- [52] . Indeed, inadequate blood supply 14 through branches of the hepatic artery and peribiliary vascular plexus results in ischemic 15 cholangiopathy, which constitutes one of the most common complications following liver 16 transplantation [4], [52] . Consequently, the supply of oxygen and nutrients through an 17 adequately vascularized stroma is essential for the long term survival of bioengineered bile 18
ducts. 19
However, the generation of vascular networks remains a key outstanding challenge in tissue 20 engineering for the fabrication of thick tissue constructs and tissues with thickness greater 21 than 400 μm require conduits for the delivery of metabolites and the removal of waste products 22
[37]. Without such a system, highly populated cellularized constructs maintain inadequate 23 metabolic activity, can form necrotic regions, and are limited in functionality. 24
To address this challenge, multiple vascularization methods have been devised and can be 25 classified in two main categories: Cellular co-culture systems and vascular network formation 26 by materials processing. While the generation of vascular networks is outside the scope of 27 this review, the key approaches and challenges are summarized below. 28
In cellular co-culture systems, capillary networks are formed through seeding of endothelial 1 and supporting cell types onto [53] or inside [54] a hydrogel construct. Prior to in vivo 2 implantation, cells can be induced to form capillary-like structures [55] which, when the 3 construct is surgically implanted, integrate into the native vasculature and can permit perfusion 4 with blood [56] . A tissue construct that has been 'pre-vascularized' to form capillary-sized 5 vessels is advantageous over an acellular construct, as the interconnecting network will rapidly 6 integrate with the host vasculature and adapt dynamically to the metabolic requirements of 7 the tissue. However, co-culture systems such as this require biologically-active polymers, such 8 as collagen and fibrin, usually in low concentrations and with limited crosslinking, which limits 9 the mechanical strength of the scaffold. Furthermore, incorporation of other signaling factors, 10 such as VEGF and bFGF, may also be required in order to form vessels. This greatly limits 11 the choice of materials that can be used for the replacement bile duct. Importantly, capillary 12 networks cannot be surgically anastomosed to existing vessels and therefore require some 13 time to form connections with the native vasculature. 14 Vascular network formation via processing of biomaterials is an active field of research [43] 
Advances in the generation of bioengineered bile ducts 21
The advances described above have set the foundation for the generation and transplantation 22 of the first bioengineered bile ducts. So far, 3 different approaches for the development of 23 engineered bile ducts have been described (Table 1) However, these approaches also have limitations. The use of PGA scaffolds resulted in foreign 19 body reaction early on, which was resolved by 8 months; while 55% of the animals were 20 complicated by bile leak, cholangitis or biliary obstruction [63] . Cholangiography revealed CBD 21 dilatation in the surviving animals but no stricture or abnormalities in liver function [63] . The 22 use of collagen tubes resulted in epithelized tubes but with lower expression of biliary markers 23 compared to the native CBD cholangiocytes [32] , [62] . PCL/PLA tubes were associated with 24 thickening of the neo-CBD connective tissue at 6 months [27] . Furthermore, the surgical 25 approach used was the equivalent of a choledochoduodenostomy with the distal end of the 26 PCL/PLA construct anastomosed to the duodenum rather than an end-to-end anastomosis to 27 the distal CBD and the presence or absence of biliary tree dilatation was not assessed with 28 cholangiography [27]. Despite these limitations, the use of PCL/PLA is associated with the 1 best outcomes described for an acellular construct. Finally, Polytetrafluoroethylene (PTFE) 2 vascular grafts have also been used [69]; however, these resulted in asymptomatic bile duct 3 dilatation, the animals were followed up for 8 days and no histological analyses of the grafts 4 was performed [69]. 5
BMC-populated constructs 6
Despite the promising results from the use of acellular tubes in animals, these constructs are 7 not functional at the time of transplantation and it is possible that they might not be as readily 8 populated by human cholangiocytes due to intra-species variation between pig and human. 9
More importantly, all the studies using acellular constructs which were outlined in the previous 10 section were performed in healthy animals. However, it is not clear if re-epithelization with 11
native cholangiocytes can take place as rapidly or effectively following transplantation of an 12 engineered conduit into a diseased/pathological niche. Consequently, while the incorporation 13 of cholangiocytes into the scaffold may seem unnecessary in normal animals, this may not be 14 the case in diseased states. 15
To address this challenge, PCL/PLA tubes seeded with Bone Marrow Cells (BMCs) were 16 transplanted in pigs anticipating differentiation of the BMCs into cholangiocytes [27] . The BMC 17 populated tubes were compared to acellular transplanted PCL/PLA constructs. However, no 18 difference in animal survival, liver function or histology was observed between the two groups 19
[27]; while survival and differentiation of BMCs into cholangiocytes was not demonstrated [27] . 20
Constructs populated with human cholangiocytes 21
More recently, densified collagen tubes populated with primary extrahepatic cholangiocyte 22 organoids (ECOs) were used to generate functional bio-engineered bile ducts in vitro 23 exhibiting GGT and ALP activity [18] . These tubes were subsequently transplanted into 24 immune compromised mice using end-to-end anastomosis and replaced the native CBD of 25 these animals [18] . Following transplantation, the lumen of the constructs remained populated 26 by human cholangiocytes retaining the expression of structural (CK7) and functional (CFTR) 27 biliary markers, as well as GGT and ALP activity, while the patency of the biliary tree was 28 confirmed using Magnetic Resonance Cholangiopancreatography (MRCP) and 1 cholangiogram [18] . Considered collectively, these studies suggest that the transplantation of 2 cholangiocyte-populated tubular scaffolds could represent an ideal therapeutic approach for 3 cholangiopathies characterized by defects in bile duct formation and regeneration, such as 4 biliary atresia. 
